Cargando…

Plasma copeptin as a predictor of kidney disease

BACKGROUND: Plasma copeptin, a marker of vasopressin, is associated with renal function decline in the general population. Our aim was to study the links between elevated copeptin and future risk of kidney disease. METHODS: Copeptin was measured in a sample of the Malmö Preventive Project (MPP) Rein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enhörning, Sofia, Christensson, Anders, Melander, Olle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322441/ https://www.ncbi.nlm.nih.gov/pubmed/29471407 http://dx.doi.org/10.1093/ndt/gfy017

Ejemplares similares

Response to Letter to the Editor: “Water Supplementation Reduces Copeptin and Plasma Glucose in Adults with High Copeptin: The H(2)O Metabolism Pilot Study”
por: Enhörning, Sofia, et al.
Publicado: (2019)

Copeptin is an independent predictor of diabetic heart disease and death
por: Enhörning, Sofia, et al.
Publicado: (2015)

High Salt Intake Increases Copeptin but Salt Sensitivity Is Associated with Fluid Induced Reduction of Copeptin in Women
por: Tasevska, Irina, et al.
Publicado: (2014)

Effect of increased water intake on plasma copeptin in healthy adults
por: Lemetais, Guillaume, et al.
Publicado: (2017)

Copeptin as a marker of atherosclerosis and arteriosclerosis
por: Schill, Fredrika, et al.
Publicado: (2021)

Copeptin as a predictive marker of incident heart failure
por: Schill, Fredrika, et al.
Publicado: (2021)

The association of copeptin with metabolic risk markers is modified by region of origin
por: Franzén, Anna, et al.
Publicado: (2023)

Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans
por: Enhörning, Sofia, et al.
Publicado: (2017)

Water Supplementation Reduces Copeptin and Plasma Glucose in Adults With High Copeptin: The H(2)O Metabolism Pilot Study
por: Enhörning, Sofia, et al.
Publicado: (2018)

Investigation of possible underlying mechanisms behind water-induced glucose reduction in adults with high copeptin
por: Enhörning, Sofia, et al.
Publicado: (2021)

Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity
por: Barchetta, Ilaria, et al.
Publicado: (2019)

Short-term association between outdoor temperature and the hydration-marker copeptin: a pooled analysis in five cohorts
por: Timpka, Simon, et al.
Publicado: (2023)

Basal Plasma Levels of Copeptin are Elevated in Inactive Inflammatory Bowel Disease after Bowel Resection
por: Ohlsson, Bodil, et al.
Publicado: (2015)

Copeptin relates to a fatty liver and measures of obesity in a South African population with mixed ethnicities
por: Enhörning, Sofia, et al.
Publicado: (2019)

Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years
por: Schulz, Christina-Alexandra, et al.
Publicado: (2020)

Growth differentiation factor-15 and incident chronic kidney disease: a population-based cohort study
por: Bao, Xue, et al.
Publicado: (2021)

Serum NGAL and copeptin levels as predictors of acute kidney injury in asphyxiated neonates
por: Baumert, Małgorzata, et al.
Publicado: (2016)

Pathophysiology of copeptin in kidney disease and hypertension
por: Afsar, Baris
Publicado: (2017)

Seasonal variation of vasopressin and its relevance for the winter peak of cardiometabolic disease: A pooled analysis of five cohorts
por: Enhörning, Sofia, et al.
Publicado: (2022)

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
por: Velho, Gilberto, et al.
Publicado: (2018)

Plasma copeptin is increased and associated with smaller kidney volume in young adults born very preterm
por: Flahault, Adrien, et al.
Publicado: (2021)

Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus
por: Enhörning, Sofia, et al.
Publicado: (2016)

Copeptin: a new predictor for severe obstructive sleep apnea
por: Çınarka, Halit, et al.
Publicado: (2015)

Vasopressin-related copeptin is a novel predictor of early endothelial dysfunction in patients with adult polycystic kidney disease
por: Kocyigit, Ismail, et al.
Publicado: (2016)

Distribution of plasma copeptin levels and influence of obesity in children and adolescents
por: Tuli, Gerdi, et al.
Publicado: (2020)

Serum copeptin as a predictor of risk of hyponatremia after transurethral prostatectomy
por: Bryc-Walczak, Katarzyna, et al.
Publicado: (2023)

Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study
por: Schulz, Christina-Alexandra, et al.
Publicado: (2016)

Predictive Value of Plasma Copeptin Level in Children with Acute Heart Failure
por: El Amrousy, Doaa, et al.
Publicado: (2022)

Cystatin C Is Not Causally Related to Coronary Artery Disease
por: Svensson-Färbom, Patrik, et al.
Publicado: (2015)

Copeptin in anorexia nervosa
por: Goetze, Jens P., et al.
Publicado: (2020)

Copeptin is a strong and independent predictor of outcome in cardiogenic shock
por: Meyer, B, et al.
Publicado: (2009)

Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
por: Velho, Gilberto, et al.
Publicado: (2013)

Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
por: Schulz, Christina-Alexandra, et al.
Publicado: (2019)

Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease
por: Michon-Colin, Arthur, et al.
Publicado: (2023)

Arginine-vasopressin marker copeptin is a sensitive plasma surrogate of hypoxic exposure
por: Ostergaard, Louise, et al.
Publicado: (2014)

Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker
por: North, William G
Publicado: (2023)

Copeptin under glucagon stimulation
por: Lewandowski, Krzysztof C., et al.
Publicado: (2015)

Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?
por: Tasneem, Moomal, et al.
Publicado: (2018)

Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
por: Golembiewska, Edyta, et al.
Publicado: (2020)

Copeptin, Procalcitonin and Routine Inflammatory Markers–Predictors of Infection after Stroke
por: Fluri, Felix, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v2du1httksjavbj62ugcfolu5b